New aspects of the physiology of the GH-IGF-1 axis

Endocrine Development

Volumn 24, Issue , 2013, Pages 96-105

  Vottero, Alessandra ^a   Guzzetti, Chiara ^b   Loche, Sandro ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Osp Regionale per le Microcitemie   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STAT PROTEIN;

ANOREXIA; ARTICLE; CENTRAL NERVOUS SYSTEM; EPIGENETICS; GENETIC REGULATION; GROWTH DISORDER; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE BINDING; HORMONE DETERMINATION; HORMONE STRUCTURE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; IN VITRO STUDY; NONHUMAN; NUTRITION; OBESITY; OVERNUTRITION; PHYSIOLOGY; PRIORITY JOURNAL; SHORT STATURE; SIGNAL TRANSDUCTION;

EID: 84875468539     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000342573     Document Type: Article

References (39)

1. Waters MJ, Hoang HN, Fairlie DP, Pelekanos RA, Brown RJ: New insights into growth hormone action. J Mol Endocrinol 2006;36:1-7.
2. Brooks AJ, Wooh JW, Tunny KA, Waters MJ: Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol 2008;40:1984-1989.
3. Waters MJ, Brooks AJ: Growth hormone receptor: structure function relationships. Horm Res Paediatr 2011;(suppl 1):12-16.
4. Rotwein P: Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit. Trends Endocrinol Metab 2012;23:186-193.
5. Veldhuis JD, Roemmich JN, Richmond EJ, Bowers CY: Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Rev 2006;27:101-140.
6. Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E: Negative regulation of growth hormone receptor signaling. Mol Endocrinol 2006; 20:241-253.
7. Rotwein P, Chia DJ: Gene regulation by growth hormone. Pediatr Nephrol 2010;25:651-658.
8. Hwa V, Nadeau K, Wit JM, Rosenfeld RG: STAT5b deficiency: lessons from STAT5b gene mutations. Best Pract Res Clin Endocrinol Metab 2011;25: 61-75.
9. Barclay JL, Kerr LM, Arthur L, Rowland JE, Nelson CN, Ishikawa M, d'Aniello EM, White M, Noakes PG, Waters MJ: In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2. Mol Endocrinol 2010;24: 204-217.
10. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van dB, I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD: PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 2002; 70:1555-1563.
11. Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le BY: Noonan syndrome: relationships between genotype, growth, and growth factors. J Clin Endocrinol Metab 2006; 91:300-306.
12. Binder G, Neuer K, Ranke MB, Wittekindt NE: PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome. J Clin Endocrinol Metab 2005;90:5377-5381.
13. De Rocca Serra-Ndlec A, Edouard T, Treguer K, Tajan M, Araki T, Dance M, Mus M, Montagner A, Tauber M, Salles JP, Valet P, Neel BG, Raynal P, Yart A: Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. Proc Natl Acad Sci U S A 2012;109:4257-4262.
14. Wu X, Simpson J, Hong JH, Kim KH, Thavarajah NK, Backx PH, Neel BG, Araki T: MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. J Clin Invest 2011; 121:1009-1025.
15. Greenhalgh CJ, Alexander WS: Suppressors of cytokine signalling and regulation of growth hormone action. Growth Horm IGF Res 2004;14:200-206.
16. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ: SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 2005;115:397-406.
17. Pass C, Macrae VE, Huesa C, Ahmed SF, Farquharson C: SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis. J Bone Miner Res 2012;27:1055-1066.
18. Vesterlund M, Zadjali F, Persson T, Nielsen ML, Kessler BM, Norstedt G, Flores-Morales A: The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One 2011;6:e25358.
19. Weedon MN, Lango H, Lindgren CM, et al: Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008;40: 575-583.
20. Ahmed SF, Farquharson C: The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 2010;206:249-259.
21. Cappa M, Loche S: Evaluation of growth disorders in the paediatric clinic. J Endocrinol Invest 2003; 26:54-63.
22. Loche S, Bizzarri C, Maghnie M, Faedda A, Tzialla C, Autelli M, Casini MR, Cappa M: Results of early reevaluation of growth hormone secretion in short children with apparent growth hormone deficiency. J Pediatr 2002;140:445-449.
23. Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F: Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999;84:1324-1328.
24. Miller KK: Endocrine dysregulation in anorexia nervosa update. J Clin Endocrinol Metab 2011;96: 2939-2949.
25. Kreitschmann-Andermahr I, Suarez P, Jennings R, Evers N, Brabant G: GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr 2010;73: 153-160.
26. Bouhours-Nouet N, Gatelais F, Boux de CF, Rouleau S, Coutant R: The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 2007;92:629-635.
27. Gleeson HK, Lissett CA, Shalet SM: Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005;90:1061-1067.
28. Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, Thorner MO: Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 1988;81:968-975.
29. Cornford AS, Barkan AL, Horowitz JF: Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab 2011;96:824-830.
30. Stanley TL, Levitsky LL, Grinspoon SK, Misra M: Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab 2009;94: 4875-4881.
31. Lee HS, Hwang JS: Influence of body mass index on growth hormone responses to classic provocative tests in children with short stature. Neuroendocrinology 2011;93:259-264.
32. Loche S, Guzzetti C, Pilia S, Ibba A, Civolani P, Porcu M, Minerba L, Casini MR: Effect of body mass index on the growth hormone response to clonidine stimulation testing in children with short stature. Clin Endocrinol (Oxf) 2011;74:726-731.
33. Bonert VS, Elashoff JD, Barnett P, Melmed S: Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab 2004;89:3397-3401.
34. Corneli G, Di SC, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G: The cutoff limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 2005;153:257-264.
35. Colao A, Di SC, Savastano S, Rota F, Savanelli MC, Aimaretti G, Lombardi G: A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. J Clin Endocrinol Metab 2009;94:4414-4422.
36. Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A: Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 2010;95:369-374.
37. Clayton P, Maisonobe P, Dutailly P: High prevalence of insulin-like growth factor-I deficiency in idiopathic short stature children. Endocr Rev 2011; 32:P1-725.
38. Chia DJ, Young JJ, Mertens AR, Rotwein P: Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription. Mol Endocrinol 2010;24:779-789.
39. Chia DJ, Rotwein P: Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription. Mol Endocrinol 2010;24:2038-2049.